Afeditab CR
Afeditab CR is an extended-release formulation of nifedipine, which is a calcium channel blocker. It relaxes the muscles of your heart and blood vessels to lower blood pressure, improve blood flow, and reduce the workload on the heart.
Dosage by Body Weight
The usual starting dose is 30 mg to 60 mg taken orally once daily. Tablets must be swallowed whole and should not be crushed, chewed, or divided. Dosage adjustments should be made under the supervision of a healthcare provider.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness of nifedipine extended-release in pediatric patients have not been established. |
Formulation
Tablet
Purpose
Used to treat hypertension (high blood pressure) and to prevent or control chronic stable angina (chest pain).
Generic Name
NifedipineScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.